BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18812216)

  • 1. The toxicology of Clioquinol.
    Mao X; Schimmer AD
    Toxicol Lett; 2008 Nov; 182(1-3):1-6. PubMed ID: 18812216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clioquinol - a novel copper-dependent and independent proteasome inhibitor.
    Schimmer AD
    Curr Cancer Drug Targets; 2011 Mar; 11(3):325-31. PubMed ID: 21247386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,1'-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: a new potential copper chelator agent for neuroprotection in Alzheimer's disease. Its comparative effects with clioquinol on rat brain copper distribution.
    Moret V; Laras Y; Pietrancosta N; Garino C; Quéléver G; Rolland A; Mallet B; Norreel JC; Kraus JL
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3298-301. PubMed ID: 16581247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Various effects of halogenated oxyquinolines inducing neurotoxic symptoms in the animal organism].
    Zeiller P; Sensch KH; Dahme E
    Arzneimittelforschung; 1972 Aug; 22(8):1307-12. PubMed ID: 4264180
    [No Abstract]   [Full Text] [Related]  

  • 5. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders.
    Bareggi SR; Cornelli U
    CNS Neurosci Ther; 2012 Jan; 18(1):41-6. PubMed ID: 21199452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary bladder effects after oral dosages of the antidiarrhoeal drug (clioquinol/phanquinone/oxyphenonium bromide) in experimental dogs.
    Chaiyabutr N; Tesprateep T; Loypetjra P; Pichaicharnarong A
    J Med Assoc Thai; 1985 Dec; 68(12):649-53. PubMed ID: 2937868
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and distribution of clioquinol in golden hamsters.
    Bondiolotti G; Sala M; Pollera C; Gervasoni M; Puricelli M; Ponti W; Bareggi SR
    J Pharm Pharmacol; 2007 Mar; 59(3):387-93. PubMed ID: 17331342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [SMON and pharmacokinetics of chinoform with special reference to animal species difference].
    Matsuki Y; Yoshimura S; Abe M
    Yakugaku Zasshi; 1997 Nov; 117(10-11):936-56. PubMed ID: 9414602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs. II. Pathology.
    Hoover DM; Carlton WW
    Vet Pathol; 1981 Nov; 18(6):757-68. PubMed ID: 6457438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs. I. Clinical disease.
    Hoover DM; Carlton WW
    Vet Pathol; 1981 Nov; 18(6):745-56. PubMed ID: 6457437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oral toxicity of clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs.
    Heywood R; Chesterman H; Worden AN
    Toxicology; 1976 Jun; 6(1):41-6. PubMed ID: 133475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The solution structure of the copper clioquinol complex.
    Pushie MJ; Nienaber KH; Summers KL; Cotelesage JJ; Ponomarenko O; Nichol HK; Pickering IJ; George GN
    J Inorg Biochem; 2014 Apr; 133():50-6. PubMed ID: 24503514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SMON--a model of the iatrogenic disease].
    Takasu T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):866-9. PubMed ID: 15152488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal activity of polymodal receptors induced by clioquinol (5-chloro-7-iodo-8-hydroxyquinoline).
    Kumazawa T; Mizumura K
    Brain Res; 1984 Sep; 310(1):185-8. PubMed ID: 6236872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effect of clioquinol for Alzheimer disease].
    Iwata N
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):223. PubMed ID: 18421848
    [No Abstract]   [Full Text] [Related]  

  • 16. Clioquinol: absence of neurotoxicity in laboratory animals.
    Hess R; Keberle H; Koella WP; Schmid K; Gelzer J
    Lancet; 1972 Aug; 2(7774):424-5. PubMed ID: 4115240
    [No Abstract]   [Full Text] [Related]  

  • 17. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells.
    Tuller ER; Brock AL; Yu H; Lou JR; Benbrook DM; Ding WQ
    Biochem Pharmacol; 2009 May; 77(9):1480-6. PubMed ID: 19426685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Further study on the neurotoxicity of clioquinol in beagle dogs (author's transl)].
    Tateishi J; Kuroda S; Ikeda H
    Seishin Shinkeigaku Zasshi; 1975 May; 77(5):378-82. PubMed ID: 144926
    [No Abstract]   [Full Text] [Related]  

  • 19. Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline).
    Jiang H; Taggart JE; Zhang X; Benbrook DM; Lind SE; Ding WQ
    Cancer Lett; 2011 Dec; 312(1):11-7. PubMed ID: 21899946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurotoxicity of clioquinol. 3. Autoradiographic distribution of radioactive clioquinol in several species of animals].
    Tateishi J; Kuroda S; Watanabe S; Otsuki S; Ogata M
    Seishin Shinkeigaku Zasshi; 1973 Mar; 75(3):187-96. PubMed ID: 4737887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.